VERA
Vera TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
9
U.S. public peers
Grade Position
Above peers
vs peer average
VERA vs peer average
70/100
VERA vs. peer average (B vs. C)
Grade spread
B 2 · C 4 · D 2 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
ARQT is the first available peer comparator.
Arcutis is mainly a same-cap biotech comparison rather than an indication peer; it highlights how single-product or narrow-portfolio biotechs can rerate sharply on execution but does not offer a close read-through for IgAN regulatory risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
VERA
Vera Therapeutics
ARQT
Arcutis Biotherapeutics
Grade
B
B
Momentum
75
84
Value
41
49
Sentiment
62
42
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ARQT
VERA / ARQT
Grade Position
Above peers
VERA vs. peer average (B vs. C)
70/100
Momentum
75
ARQTValue
41
ARQTSentiment
62
VERARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs VERA
ARQT is the first peer returned for this comparison set.